Excalibur Management Corp Abbott Laboratories Transaction History

Excalibur Management Corp

$261 Million
Q3 2024

A detailed history of Excalibur Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Excalibur Management Corp holds 13,918 shares of ABT stock, worth $1.63 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

13,918

Previous 13,927 0.06%

Holding current value

$1.63 Million

Previous $1.45 Million 9.61%

% of portfolio

0.61%

Previous 0.59%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $900 - $1,063	-9 Reduced 0.06%	13,918 $1.59 Million
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $16,620 - $18,552	165 Added 1.2%	13,927 $1.45 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $13,361 - $14,757	-122 Reduced 0.88%	13,762 $1.56 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $32,738 - $40,075	363 Added 2.68%	13,884 $1.53 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $2,292 - $2,750	24 Added 0.18%	13,521 $1.31 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $2,015 - $2,245	-20 Reduced 0.15%	13,497 $1.47 Million
Q1 2023 May 05, 2023	SELL	$96.86 - $114.01 $4,843 - $5,700	-50 Reduced 0.37%	13,517 $1.37 Million
Q3 2022 Nov 04, 2022	SELL	$96.76 - $112.03 $2,419 - $2,800	-25 Reduced 0.18%	13,567 $1.31 Million
Q2 2022 Jul 25, 2022	SELL	$102.07 - $123.37 $4,593 - $5,551	-45 Reduced 0.33%	13,592 $1.48 Million
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $44,011 - $53,669	-386 Reduced 2.75%	13,637 $1.61 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $1,501 - $1,838	13 Added 0.09%	14,023 $1.97 Million
Q3 2021 Oct 28, 2021	SELL	$116.66 - $129.06 $10,499 - $11,615	-90 Reduced 0.64%	14,010 $1.66 Million
Q2 2021 Jul 26, 2021	SELL	$105.79 - $124.53 $29,092 - $34,245	-275 Reduced 1.91%	14,100 $1.64 Million
Q1 2021 May 03, 2021	SELL	$108.84 - $128.23 $427,741 - $503,943	-3,930 Reduced 21.47%	14,375 $1.72 Million
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $10,500 - $11,442	-100 Reduced 0.54%	18,305 $2 Million
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $9,164 - $11,129	-100 Reduced 0.54%	18,405 $2 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $306,892 - $392,784	4,008 Added 27.65%	18,505 $1.69 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $11,181 - $16,351	-178 Reduced 1.21%	14,497 $1.14 Million
Q4 2019 Feb 04, 2020	BUY	$78.51 - $87.4 $336,807 - $374,946	4,290 Added 41.31%	14,675 $1.28 Million
Q3 2019 Oct 21, 2019	SELL	$81.84 - $88.74 $882,235 - $956,617	-10,780 Reduced 50.93%	10,385 $869,000
Q2 2019 Jul 26, 2019	SELL	$72.88 - $85.0 $18,220 - $21,250	-250 Reduced 1.17%	21,165 $1.78 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $6,622 - $8,006	-100 Reduced 0.46%	21,415 $1.71 Million
Q4 2018 Jan 29, 2019	SELL	$65.56 - $74.27 $29,502 - $33,421	-450 Reduced 2.05%	21,515 $1.56 Million
Q3 2018 Oct 25, 2018	SELL	$60.81 - $73.36 $27,060 - $32,645	-445 Reduced 1.99%	21,965 $1.61 Million
Q1 2018 Apr 23, 2018	SELL	$56.27 - $63.62 $11,254 - $12,724	-200 Reduced 0.88%	22,410 $1.34 Million
Q4 2017 Jan 22, 2018	SELL	$53.68 - $57.47 $6,978 - $7,471	-130 Reduced 0.57%	22,610 $1.29 Million
Q3 2017 Oct 25, 2017	BUY	$48.06 - $53.64 $1.09 Million - $1.22 Million	22,740	22,740 $1.21 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Excalibur Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Excalibur Management Corp with notifications on news.

Account

Excalibur Management Corp Abbott Laboratories Transaction History